CXCL11 and neoplasm: According to another study, intravenous (IV) administration of CXCL11-modified oncolytic vaccinia virus (CXCL11-OVV) in mouse tumor models can be employed to modify tumor cells to secrete CXCL11, thus increasing the intratumoral concentration of CXCL11 (92).